# Bristol-Myers Squibb Company (BMY) stock price

URL: https://funkfolio.com/stock/BMY

> Bristol-Myers Squibb Company (BMY) trades at $60.83, is worth $124.34B, is priced at 13.5× earnings and scores 57/100. Valuation, financials and signals.

---

## Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY) is a healthcare company (drug manufacturers - general) based in the United States. The share price is $60.83, down 3.34% on the day, which values the company at $124.34B. Price as of 17 Nov 2026, 19:32 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $60.83 −3.34% today
- **Market value:** $124.34B
- **P/E ratio:** 13.5× last 12 months
- **Forward P/E:** 9.1×
- **Dividend yield:** 4.00%
- **Funk Score:** 57/100
- **Against its own history:** Below its usual price usual price $81.54
- **200-week average:** $55.30 10% above

Figures as of 17 Nov 2026, 19:32 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Bristol-Myers Squibb Company in more detail

BMY trades at 13.5× its last twelve months' earnings, 9.1× next year's expected earnings, 2.5× sales. Measured against its own history, the price is 25% below what its usual multiples would imply ($81.54) — below its usual price. It sits 10% above its 200-week average of $55.30.

Over the last five fiscal years Bristol-Myers Squibb Company has compounded revenue 2.5% a year, free cash flow -0.7% a year. Its Funk Score is 57 out of 100 (financial strength 5.0, profitability 9.0, growth 2.3, value 6.7, each out of 10).

In its favour: Strong Piotroski score; High return on invested capital.

15 of the superinvestors tracked here hold BMY, including Richard Pzena (2.6% of the portfolio), Thomas Kahn (1.6% of the portfolio), Josef Lakonishok (1.1% of the portfolio).

### Superinvestors holding BMY

15 of the investors tracked here report a position in their latest 13F filing.

- [Richard Pzena Pzena Investment Management](https://funkfolio.com/gurus/richard-pzena) 2.61% of portfolio · $888.9M · trimmed · Q3 2026
- [Thomas Kahn Kahn Brothers](https://funkfolio.com/gurus/thomas-kahn) 1.61% of portfolio · $9.7M · trimmed · Q3 2026
- [Josef Lakonishok LSV Asset Management](https://funkfolio.com/gurus/josef-lakonishok) 1.10% of portfolio · $592.6M · trimmed · Q3 2026
- [Primecap team Primecap Management](https://funkfolio.com/gurus/primecap) 0.98% of portfolio · $1.6B · added · Q3 2026
- [Bill Miller (founder) Miller Value Partners](https://funkfolio.com/gurus/bill-miller) 0.94% of portfolio · $4.3M · Q3 2026
- [Cliff Asness AQR Capital Management](https://funkfolio.com/gurus/cliff-asness) 0.55% of portfolio · $1.6B · trimmed · Q2 2026
- [Mark Boyar Boyar Asset Management](https://funkfolio.com/gurus/mark-boyar) 0.47% of portfolio · $754.3K · trimmed · Q3 2026
- [John Rogers Ariel Investments](https://funkfolio.com/gurus/john-rogers) 0.43% of portfolio · $41.3M · trimmed · Q3 2026
- [John Overdeck and David Siegel (founders) Two Sigma Investments](https://funkfolio.com/gurus/two-sigma) 0.36% of portfolio · $491.7M · trimmed · Q3 2026
- [Tweedy, Browne team Tweedy, Browne Company](https://funkfolio.com/gurus/tweedy-browne) 0.22% of portfolio · $2.7M · added · Q3 2026
- [Jeremy Grantham (co-founder) GMO (Grantham, Mayo, Van Otterloo)](https://funkfolio.com/gurus/jeremy-grantham) 0.06% of portfolio · $28.9M · added · Q3 2026
- [Murray Stahl Horizon Kinetics](https://funkfolio.com/gurus/murray-stahl) 0.03% of portfolio · $2.7M · trimmed · Q3 2026
- [Mairs & Power team Mairs & Power](https://funkfolio.com/gurus/mairs-and-power) 0.01% of portfolio · $1.5M · Q3 2026
- [Rajiv Jain GQG Partners](https://funkfolio.com/gurus/rajiv-jain) 0.01% of portfolio · $6M · trimmed · Q3 2026
- [Sarah Ketterer Causeway Capital Management](https://funkfolio.com/gurus/sarah-ketterer) 0.00% of portfolio · $229.2K · new · Q3 2026

### Health Care companies of similar size

- [Pfizer PFE](https://funkfolio.com/stock/PFE)
- [Danaher DHR](https://funkfolio.com/stock/DHR)
- [Intuitive Surgical ISRG](https://funkfolio.com/stock/ISRG)
- [Vertex Pharmaceuticals VRTX](https://funkfolio.com/stock/VRTX)
- [Medtronic MDT](https://funkfolio.com/stock/MDT)
- [Stryker SYK](https://funkfolio.com/stock/SYK)
- [McKesson MCK](https://funkfolio.com/stock/MCK)
- [Sanofi SNY](https://funkfolio.com/stock/SNY)
- [Moderna MRNA](https://funkfolio.com/stock/MRNA)
- [CVS Health CVS](https://funkfolio.com/stock/CVS)
- [HCA Healthcare HCA](https://funkfolio.com/stock/HCA)
- [GSK GSK](https://funkfolio.com/stock/GSK)

Side by side: [BMY vs MDT (Bristol-Myers Squibb Company vs Medtronic)](https://funkfolio.com/compare/bmy-vs-mdt) [BMY vs SYK (Bristol-Myers Squibb Company vs Stryker)](https://funkfolio.com/compare/bmy-vs-syk) [BMY vs MCK (Bristol-Myers Squibb Company vs McKesson)](https://funkfolio.com/compare/bmy-vs-mck) [BMY vs VRTX (Bristol-Myers Squibb Company vs Vertex Pharmaceuticals)](https://funkfolio.com/compare/bmy-vs-vrtx) [BMY vs SNY (Bristol-Myers Squibb Company vs Sanofi)](https://funkfolio.com/compare/bmy-vs-sny)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Bristol-Myers Squibb Company (BMY): questions and answers

**What is BMY's P/E ratio?**

Bristol-Myers Squibb Company trades at 13.5× its last twelve months' earnings and 9.1× next year's expected earnings. At its fiscal year-ends over the past 17 years the P/E ranged from 4.7× to 100.5×, with a median of 22.1×.

**What is BMY's PEG ratio?**

Bristol-Myers Squibb Company's PEG ratio is 17.39 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Bristol-Myers Squibb Company's market cap?**

Bristol-Myers Squibb Company is valued at $124.34B at a share price of $60.83.

**Is BMY overvalued or undervalued?**

Against its own history, BMY is below its usual price: the price is 25% below the $81.54 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is BMY above its 200-week moving average?**

Yes. BMY is 10.0% above its 200-week average of $55.30. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Bristol-Myers Squibb Company growing?**

Over the last five fiscal years Bristol-Myers Squibb Company's revenue grew 2.5% a year; over ten years revenue grew 11.3% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Bristol-Myers Squibb Company (BMY) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BMY

Underlying data: Yahoo Finance; company filings with the SEC.
